U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06804603) titled 'A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use' on Jan. 09.
Brief Summary: The goal of this study is to measure the effects of using Tradipitant after GLP-1R agonist use on nausea and vomiting in healthy overweight, class I, or class II obese volunteers. The study is placebo-controlled with two treatment arms.
Study Start Date: Jan. 26
Study Type: INTERVENTIONAL
Condition:
Obesity
Intervention:
DRUG: Tradipitant
Oral capsule
DRUG: Placebo
Oral capsule
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Vanda Pharmaceuticals
Published by HT Digital Content Services with perm...